Novus Acquisition (OTC: NDEV) Continues to Thrive Despite Cannabis Space Challenges

This morning most investors are expected to look into the stocks of those companies that had been in the news cycle on Monday, and hence, the Novus Acquisition & Development Corp. (OTC: NDEV) stock could be the one worth tracking. Yesterday, the company sent out a key news release, and in this feature, we will look into some of the highlights.

Key Highlights

In the news release, Novus Acquisition & Development Corp. noted that it was involved in the non-touching cannabis space and that was a highly important but routinely underestimated part of the industry. In 2025, the company would look into a move into the dental and prescription drug plans. Such a move would provide the company with tax deductions on premiums inclusive of cannabis benefits at no cost to the company.

Further Information

The company also revealed that in the past three years, none of the insiders sold their shares, and that demonstrated the confidence in the future of Novus Acquisition. Another key point for shareholders was the revelation that the total shareholder equity had actually gone up by as much as 5.3% as of December 31, 2024.

Fundamentals

P/E Ratio	27.1800
PEG Ratio	2.07
Price to Book	3.37
Price to Cash Flow	–
Price to Free Cash Flow	–
Total Sales (TTM)	0.46 M
Revenue per Share (TTM)	0.00
Shares Outstanding	97.854 M
Share Float (%)	97.85 M (100.00%)
% Held by Institutions	0.00